EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Unravelling the therapeutic landscape of bile acid-based therapies in gastrointestinal disorders

Bandar D Alrehaili iD

Saudi Journal of Gastroenterology · 2024

DOI: 10.4103/sjg.sjg_53_24 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Saudi Journal of Gastroenterology, 2024. Verfasst von Bandar D Alrehaili. Beteiligte Einrichtung: Pharmacology and Toxicology Department, Pharmacy College, Taibah University, Medina, Saudi Arabia. Hauptthemen laut MEDLINE: Bile Acids and Salts, Receptors, Cytoplasmic and Nuclear, Gastrointestinal Diseases. Die Arbeit nennt 71 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bile acids serve as endogenous ligands for nuclear and cell membrane receptors and play a crucial role in bile acid and lipid metabolism. These detergent-like compounds promote bile flow and aid in the absorption of dietary fats and fat-soluble vitamins in the intestine. Synthesized in the liver as end products of cholesterol catabolism, bile acids exhibit a chemical structure comprising a nucleus and a side chain featuring a carboxyl group, with diverse steric arrangements and potential polar substituents. Critical interactions occur between bile acid species and various nuclear and cell membrane receptors, including the farnesoid X receptor and G-protein–coupled bile acid receptor 1. This research aimed to review the literature on bile acids and their roles in treating different diseases. Currently, numerous investigations are concentrating on specific bile acid species that target nuclear receptors in the gastrointestinal system, aiming to improve the treatment of conditions such as nonalcoholic fatty liver disease. Given the global attention this topic has garnered from research groups, it is considered relatively new, thus anticipating some gaps or incomplete data. Bile acid species have a significant therapeutic promise, especially in their ability to activate or inhibit nuclear receptors, such as farnesoid X receptor. This research provides to offer essential information for scientists and medical practitioners interested in discovering new studies that underscore the importance of bile acids in ameliorating and impeding the progression of disorders. Furthermore, it opens avenues for previously overlooked bile acid–based therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bile Acids and SaltsReceptors, Cytoplasmic and NuclearGastrointestinal DiseasesHumansNon-alcoholic Fatty Liver DiseaseReceptors, G-Protein-CoupledLipid MetabolismAnimalsReceptor, Farnesoid X-Activated

Substanzen

Bile Acids and SaltsReceptors, Cytoplasmic and NuclearReceptors, G-Protein-CoupledReceptor, Farnesoid X-Activated

Autor:innen und Institutionen

  • Pharmacology and Toxicology Department, Pharmacy College, Taibah University, Medina, Saudi Arabia.

ORCID-Profile: Bandar D Alrehaili

Zitieren

APA

Alrehaili, B. D. (2024). Unravelling the therapeutic landscape of bile acid-based therapies in gastrointestinal disorders. Saudi Journal of Gastroenterology. https://doi.org/10.4103/sjg.sjg_53_24

Vancouver

Alrehaili BD. Unravelling the therapeutic landscape of bile acid-based therapies in gastrointestinal disorders. Saudi Journal of Gastroenterology. 2024. doi:10.4103/sjg.sjg_53_24

BibTeX
@article{Alrehaili2024,
  author = {Alrehaili, Bandar D},
  title = {Unravelling the therapeutic landscape of bile acid-based therapies in gastrointestinal disorders},
  journal = {Saudi Journal of Gastroenterology},
  year = {2024},
  doi = {10.4103/sjg.sjg_53_24}
}
Kostenlos starten →